![Gabriele Cerrone](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gabriele Cerrone
Fondateur chez
ACCM SCIE
Fortune : 75 M $ au 30/06/2026
Profil
Gabriele Marco Antonio Cerrone is the founder of Tiziana Life Sciences Ltd. (United Kingdom) founded in 1998, holding the titles of Executive Chairman & Chief Executive Officer and Executive Chairman since 2024.
Founder of Cardiff Oncology, Inc. founded in 1999, served as Co-Chairman in 2006.
Founder of FermaVir Pharmaceuticals LLC founded in 2004, served as Chairman from 2004 to 2007.
Founder of Synergy Pharmaceuticals LLC founded in 2008, served as Chairman.
Founder of Rasna Therapeutics, Inc. founded in 2013, served as Chairman.
Founder of AccuStem Sciences, Inc. founded in 2020, serving as Non-Executive Chairman since 2021.
Mr. Cerrone is also the founder of Hepion Pharmaceuticals, Inc.,Arna Therapeutics Ltd.,Biovitas Capital Ltd.,Gensignia Life Sciences, Inc.,Gensignia Ltd...
Current positions include Executive Chairman & Managing Partner at Panetta Partners Ltd. since 2013, Non-Executive Chairman at OKYO Pharma Ltd. since 2021, and Director at Gensignia IP Ltd. since 2014.
Former positions include Chairman at Callisto Pharmaceuticals, Inc. from 2003 to 2013, Director at SIGA Technologies, Inc. in 2003, Independent Director at Inhibitex LLC from 2011 to 2012, Director at Pawfect Foods, Inc., Managing Director-Investments at Barrington Capital Group LP in 1999, and Senior Vice President-Investments at Oppenheimer & Co., Inc. from 1999 to 2005.
Education includes an MBA from The Leonard N Stern School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 21/07/2026 | 44 814 587 ( 34,93% ) | 57 M $ | 30/06/2026 | |
OKYO PHARMA LIMITED 21,17% | 22/07/2026 | 10 873 916 ( 21,17% ) | 16 M $ | 30/06/2026 |
| 13/06/2025 | 4 950 355 ( 30,8% ) | 1 M $ | 30/06/2026 |
Postes actifs de Gabriele Cerrone
| Sociétés | Poste | Début |
|---|---|---|
| WEST AFRICAN MINERALS CORP | Président | 07/01/2021 |
| ACCM SCIE | Fondateur | 05/06/2020 |
| TIZIANA LIFE SCIENCES LTD | Fondateur | 11/02/1998 |
Gensignia IP Ltd.
 Gensignia IP Ltd. Miscellaneous Commercial ServicesCommercial Services Provides professional, scientific and technical services | Directeur/Membre du Conseil | 23/04/2014 |
Biovitas Capital Ltd. | Fondateur | - |
Arna Therapeutics Ltd.
 Arna Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on biotechnology | Fondateur | - |
Tiziana Life Sciences Ltd. (United Kingdom)
 Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops transformative therapies for neurodegenerative and neuroinflammatory | Directeur Général | - |
Panetta Partners Ltd.
 Panetta Partners Ltd. Financial ConglomeratesFinance Private equity firm, primarily for technology companies | Président | 12/08/2013 |
Anciens postes connus de Gabriele Cerrone
| Sociétés | Poste | Fin |
|---|---|---|
Gensignia Ltd. | Fondateur | 29/04/2014 |
| ░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Gabriele Cerrone
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
51
Relations au 1er degré
22
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 22 |
|---|---|
SIGA Technologies, Inc.
 SIGA Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops vaccines and antibiotics | Health Technology |
Oppenheimer & Co., Inc.
 Oppenheimer & Co., Inc. Investment ManagersFinance Provides wealth and asset management, brokerage & investment banking services | Finance |
Panetta Partners Ltd.
Panetta Partners Ltd. Financial ConglomeratesFinance Private equity firm, primarily for technology companies | Finance |
Callisto Pharmaceuticals, Inc.
 Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops novel therapeutics to treat cancer | Health Technology |
Inhibitex LLC
 Inhibitex LLC Pharmaceuticals: MajorHealth Technology Develops drugs | Health Technology |
Pawfect Foods, Inc.
 Pawfect Foods, Inc. Specialty StoresRetail Trade Sells pet food via the internet | Retail Trade |
OKYO Pharma Ltd.
 OKYO Pharma Ltd. BiotechnologyHealth Technology Develops next-generation therapeutics to improve the lives of patients suffering from inflammatory eye diseases | Health Technology |
Hepion Pharmaceuticals, Inc.
 Hepion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug therapy for treatment of chronic liver diseases | Health Technology |
Cardiff Oncology, Inc.
 Cardiff Oncology, Inc. Medical SpecialtiesHealth Technology Develops diagnostic products | Health Technology |
FermaVir Pharmaceuticals LLC
 FermaVir Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Barrington Capital Group LP | |
Synergy Pharmaceuticals LLC
 Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops drugs to treat gastrointestinal disorders and diseases | Health Technology |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tiziana Life Sciences Ltd. (United Kingdom)
Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops transformative therapies for neurodegenerative and neuroinflammatory | Health Technology |
Gensignia Ltd. | |
Arna Therapeutics Ltd.
Arna Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on biotechnology | Commercial Services |
Biovitas Capital Ltd. | |
Gensignia Life Sciences, Inc.
 Gensignia Life Sciences, Inc. BiotechnologyHealth Technology Operates as a molecular diagnostics company which develop new molecular diagnosis techniques | Health Technology |
Rasna Therapeutics, Inc. /Old/
 Rasna Therapeutics, Inc. /Old/ Medical DistributorsDistribution Services Develops cancer drugs | Distribution Services |
Gensignia IP Ltd.
Gensignia IP Ltd. Miscellaneous Commercial ServicesCommercial Services Provides professional, scientific and technical services | Commercial Services |
AccuStem Sciences, Inc.
 AccuStem Sciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures genomics-based personalized medicines for breast cancer patients | Health Technology |
Tiziana Life Sciences Ltd.
 Tiziana Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
